{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:59:05Z","timestamp":1793750345838,"version":"4.6.1"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2020,6]]},"abstract":"\n Background<\/jats:title>\n Acute treatment of cerebral edema and elevated intracranial pressure is a common issue in patients with neurological injury. Practical recommendations regarding selection and monitoring of therapies for initial management of cerebral edema for optimal efficacy and safety are generally lacking. This guideline evaluates the role of hyperosmolar agents (mannitol, HTS), corticosteroids, and selected non-pharmacologic therapies in the acute treatment of cerebral edema. Clinicians must be able to select appropriate therapies for initial cerebral edema management based on available evidence while balancing efficacy and safety.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The Neurocritical Care Society recruited experts in neurocritical care, nursing, and pharmacy to create a panel in 2017. The group generated 16 clinical questions related to initial management of cerebral edema in various neurological insults using the PICO format. A research librarian executed a comprehensive literature search through July 2018. The panel screened the identified articles for inclusion related to each specific PICO question and abstracted necessary information for pertinent publications. The panel used GRADE methodology to categorize the quality of evidence as high, moderate, low, or very low based on their confidence that the findings of each publication approximate the true effect of the therapy.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The panel generated recommendations regarding initial management of cerebral edema in neurocritical care patients with subarachnoid hemorrhage, traumatic brain injury, acute ischemic stroke, intracerebral hemorrhage, bacterial meningitis, and hepatic encephalopathy.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The available evidence suggests hyperosmolar therapy may be helpful in reducing ICP elevations or cerebral edema in patients with SAH, TBI, AIS, ICH, and HE, although neurological outcomes do not appear to be affected. Corticosteroids appear to be helpful in reducing cerebral edema in patients with bacterial meningitis, but not ICH. Differences in therapeutic response and safety may exist between HTS and mannitol. The use of these agents in these critical clinical situations merits close monitoring for adverse effects. There is a dire need for high-quality research to better inform clinicians of the best options for individualized care of patients with cerebral edema.<\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s12028-020-00959-7","type":"journal-article","created":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T21:02:50Z","timestamp":1585515770000},"page":"647-666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":417,"title":["Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Aaron M.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Morgan Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W. J.","family":"Hawryluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mailloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Papangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Venkatasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Zacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara L.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Shutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"issue":"2","key":"959_CR1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12028-007-0012-1","volume":"6","author":"MM Treggiari","year":"2007","unstructured":"Treggiari MM, Schutz N, Yanez ND, Romand J-A. Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review. Neurocrit Care. 2007;6(2):104\u201312.","journal-title":"Neurocrit Care"},{"issue":"5","key":"959_CR2","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2007.22.5.2","volume":"22","author":"A Marmarou","year":"2007","unstructured":"Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus. 2007;22(5):E1.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"959_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6\u201315.","journal-title":"Neurosurgery"},{"issue":"6","key":"959_CR4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. 2012;43(6):1711\u201337.","journal-title":"Stroke"},{"issue":"3","key":"959_CR5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(3):870\u2013947.","journal-title":"Stroke"},{"issue":"7","key":"959_CR6","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015;46(7):2032\u201360.","journal-title":"Stroke"},{"issue":"7","key":"959_CR7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","volume":"66","author":"JC Andrews","year":"2013","unstructured":"Andrews JC, Schunemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation\u2019s direction and strength. J Clin Epidemiol. 2013;66(7):726\u201335.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"959_CR8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/01.STR.0000071526.45277.44","volume":"34","author":"M-Y Tseng","year":"2003","unstructured":"Tseng M-Y, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. Stroke. 2003;34(6):1389\u201396.","journal-title":"Stroke"},{"issue":"7","key":"959_CR9","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/CCM.0b013e318218a390","volume":"39","author":"EM Hauer","year":"2011","unstructured":"Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med. 2011;39(7):1766\u201372.","journal-title":"Crit Care Med"},{"issue":"13 part 1","key":"959_CR10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1212\/01.wnl.0000304042.05557.60","volume":"70","author":"MA Koenig","year":"2008","unstructured":"Koenig MA, Bryan M, Lewin IJL, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13 part 1):1023\u20139.","journal-title":"Neurology"},{"issue":"12","key":"959_CR11","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1097\/01.CCM.0000245665.46789.7C","volume":"34","author":"G Bentsen","year":"2006","unstructured":"Bentsen G, Breivik H, Lundar T, Stubhaug A. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med. 2006;34(12):2912\u20137.","journal-title":"Crit Care Med"},{"issue":"8","key":"959_CR12","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1097\/CCM.0b013e318180fe04","volume":"36","author":"G Bentsen","year":"2008","unstructured":"Bentsen G, Stubhaug A, Eide PK. Differential effects of osmotherapy on static and pulsatile intracranial pressure. Crit Care Med. 2008;36(8):2414\u20139.","journal-title":"Crit Care Med"},{"issue":"9","key":"959_CR13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1399-6576.2004.00497.x","volume":"48","author":"G Bentsen","year":"2004","unstructured":"Bentsen G, Breivik H, Lundar T, Stubhaug A. Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in critically ill patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand. 2004;48(9):1089\u201395.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"959_CR14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/STROKEAHA.109.560698","volume":"41","author":"PG Al-Rawi","year":"2010","unstructured":"Al-Rawi PG, Tseng M-Y, Richards HK, et al. Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood flow, brain tissue oxygen, and pH. Stroke. 2010;41(1):122\u20138.","journal-title":"Stroke"},{"key":"959_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/3-211-32318-X_27","volume":"95","author":"PG Al-Rawi","year":"2005","unstructured":"Al-Rawi PG, Zygun D, Tseng MY, Hutchinson PJ, Matta BF, Kirkpatrick PJ. Cerebral blood flow augmentation in patients with severe subarachnoid haemorrhage. Acta Neurochir Suppl. 2005;95:123\u20137.","journal-title":"Acta Neurochir Suppl"},{"issue":"2","key":"959_CR16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3171\/JNS-07\/08\/0274","volume":"107","author":"M-Y Tseng","year":"2007","unstructured":"Tseng M-Y, Al-Rawi PG, Czosnyka M, et al. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg. 2007;107(2):274\u201382.","journal-title":"J Neurosurg"},{"issue":"6","key":"959_CR17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1227\/01.NEU.0000359533.16214.04","volume":"65","author":"GL Rockswold","year":"2009","unstructured":"Rockswold GL, Solid CA, Paredes-Andrade E, Rockswold SB, Jancik JT, Quickel RR. Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. Neurosurgery. 2009;65(6):1035\u201341 (discussion 1041\u20131032).","journal-title":"Neurosurgery"},{"issue":"5","key":"959_CR18","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/cc11678","volume":"16","author":"DL Wells","year":"2012","unstructured":"Wells DL, Swanson JM, Wood GC, et al. The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma. Crit Care. 2012;16(5):R193.","journal-title":"Crit Care"},{"issue":"6","key":"959_CR19","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/01.CCM.0000063268.91710.DF","volume":"31","author":"R Vialet","year":"2003","unstructured":"Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2\u00a0mL\/kg 7.5% saline is more effective than 2\u00a0mL\/kg 20% mannitol. Crit Care Med. 2003;31(6):1683\u20137.","journal-title":"Crit Care Med"},{"issue":"1","key":"959_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.CCM.0000150269.65485.A6","volume":"33","author":"C Battison","year":"2005","unstructured":"Battison C, Andrews PJD, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline\/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33(1):196\u20138.","journal-title":"Crit Care Med"},{"issue":"5","key":"959_CR21","doi-asserted-by":"crossref","first-page":"R530","DOI":"10.1186\/cc3767","volume":"9","author":"L Harutjunyan","year":"2005","unstructured":"Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup JA. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200\/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients\u2014a randomized clinical trial [ISRCTN62699180]. Crit Care. 2005;9(5):R530\u201340.","journal-title":"Crit Care"},{"issue":"4","key":"959_CR22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1227\/01.NEU.0000175726.08903.0A","volume":"57","author":"ML Ware","year":"2005","unstructured":"Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57(4):727\u201336.","journal-title":"Neurosurgery"},{"issue":"3","key":"959_CR23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/CCM.0B013E3181643B41","volume":"36","author":"G Francony","year":"2008","unstructured":"Francony G, Fauvage B, Falcon D, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36(3):795\u2013800.","journal-title":"Crit Care Med"},{"issue":"10","key":"959_CR24","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1089\/neu.2011.1929","volume":"28","author":"V Cottenceau","year":"2011","unstructured":"Cottenceau V, Masson F, Mahamid E, et al. Comparison of effects of equiosmolar doses of mannitol and hypertonic saline on cerebral blood flow and metabolism in traumatic brain injury. J Neurotrauma. 2011;28(10):2003\u201312.","journal-title":"J Neurotrauma"},{"issue":"2","key":"959_CR25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3171\/2010.5.JNS091685","volume":"114","author":"N Sakellaridis","year":"2011","unstructured":"Sakellaridis N, Pavlou E, Karatzas S, et al. Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries. J Neurosurg. 2011;114(2):545\u20138.","journal-title":"J Neurosurg"},{"issue":"3","key":"959_CR26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00134-008-1283-5","volume":"35","author":"C Ichai","year":"2009","unstructured":"Ichai C, Armando G, Orban J-C, et al. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med. 2009;35(3):471\u20139.","journal-title":"Intensive Care Med"},{"issue":"2","key":"959_CR27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1017\/cem.2016.12","volume":"18","author":"E Berger-Pelleiter","year":"2016","unstructured":"Berger-Pelleiter E, Emond M, Lauzier F, Shields JF, Turgeon AF. Hypertonic saline in severe traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials. CJEM. 2016;18(2):112\u201320.","journal-title":"CJEM"},{"issue":"17","key":"959_CR28","first-page":"e736","volume":"94","author":"M Li","year":"2015","unstructured":"Li M, Chen T, Chen SD, Cai J, Hu YH. Comparison of equimolar doses of mannitol and hypertonic saline for the treatment of elevated intracranial pressure after traumatic brain injury: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(17):e736.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"959_CR29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12028-011-9512-0","volume":"15","author":"CP Bourdeaux","year":"2011","unstructured":"Bourdeaux CP, Brown JM. Randomized controlled trial comparing the effect of 8.4% sodium bicarbonate and 5% sodium chloride on raised intracranial pressure after traumatic brain injury. Neurocrit Care. 2011;15(1):42\u20135.","journal-title":"Neurocrit Care"},{"key":"959_CR30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jocn.2015.08.035","volume":"27","author":"AT Jagannatha","year":"2016","unstructured":"Jagannatha AT, Sriganesh K, Devi BI, Rao GSU. An equiosmolar study on early intracranial physiology and long term outcome in severe traumatic brain injury comparing mannitol and hypertonic saline. J Clin Neurosci. 2016;27:68\u201373.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"959_CR31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13054-017-1918-4","volume":"21","author":"K Asehnoune","year":"2017","unstructured":"Asehnoune K, Lasocki S, Seguin P, et al. Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury\u2014a multicentre prospective cohort study and systematic review. Crit Care. 2017;21(1):328.","journal-title":"Crit Care"},{"issue":"11","key":"959_CR32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.291.11.1350","volume":"291","author":"DJ Cooper","year":"2004","unstructured":"Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA. 2004;291(11):1350\u20137.","journal-title":"JAMA"},{"issue":"13","key":"959_CR33","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2010.1405","volume":"304","author":"EM Bulger","year":"2010","unstructured":"Bulger EM, May S, Brasel KJ, et al. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA. 2010;304(13):1455\u201364.","journal-title":"JAMA"},{"issue":"9","key":"959_CR34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1553-2712.1996.tb03528.x","volume":"3","author":"MR Sayre","year":"1996","unstructured":"Sayre MR, Daily SW, Stern SA, Storer DL, van Loveren HR, Hurst JM. Out-of-hospital administration of mannitol to head-injured patients does not change systolic blood pressure. Acad Emerg Med. 1996;3(9):840\u20138.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"959_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12028-010-9465-8","volume":"14","author":"MN Diringer","year":"2011","unstructured":"Diringer MN, Scalfani MT, Zazulia AR, Videen TO, Dhar R. Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke. Neurocrit Care. 2011;14(1):11\u20137.","journal-title":"Neurocrit Care"},{"issue":"8","key":"959_CR36","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/01.STR.29.8.1550","volume":"29","author":"S Schwarz","year":"1998","unstructured":"Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29(8):1550\u20135.","journal-title":"Stroke"},{"issue":"3","key":"959_CR37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00003246-199803000-00011","volume":"26","author":"AI Qureshi","year":"1998","unstructured":"Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline\/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26(3):440\u20136.","journal-title":"Crit Care Med"},{"issue":"3","key":"959_CR38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s12028-013-9907-1","volume":"20","author":"JJ Lewandowski-Belfer","year":"2014","unstructured":"Lewandowski-Belfer JJ, Patel AV, Darracott RM, Jackson DA, Nordeen JD, Freeman WD. Safety and efficacy of repeated doses of 14.6 or 23.4% hypertonic saline for refractory intracranial hypertension. Neurocrit Care. 2014;20(3):436\u201342.","journal-title":"Neurocrit Care"},{"issue":"2","key":"959_CR39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00008506-200204000-00007","volume":"14","author":"E Keller","year":"2002","unstructured":"Keller E, Steiner T, Fandino J, Schwab S, Hacke W. Jugular venous oxygen saturation thresholds in trauma patients may not extrapolate to ischemic stroke patients: lessons from a preliminary study. J Neurosurg Anesthesiol. 2002;14(2):130\u20136.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"959_CR40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/hs0102.100877","volume":"33","author":"S Schwarz","year":"2002","unstructured":"Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33(1):136\u201340.","journal-title":"Stroke"},{"issue":"2","key":"959_CR41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.STR.9.2.130","volume":"9","author":"S Santambrogio","year":"1978","unstructured":"Santambrogio S, Martinotti R, Sardella F, Porro F, Randazzo A. Is there a real treatment for stroke? Clinical and statistical comparison of different treatments in 300 patients. Stroke. 1978;9(2):130\u20132.","journal-title":"Stroke"},{"issue":"7","key":"959_CR42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1747-4949.2012.00781.x","volume":"8","author":"D Strbian","year":"2013","unstructured":"Strbian D, Meretoja A, Putaala J, et al. Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis. Int J Stroke. 2013;8(7):529\u201334.","journal-title":"Int J Stroke"},{"issue":"2","key":"959_CR43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12028-015-0173-2","volume":"23","author":"CJ Ong","year":"2015","unstructured":"Ong CJ, Keyrouz SG, Diringer MN. The role of osmotic therapy in hemispheric stroke. Neurocrit Care. 2015;23(2):285\u201391.","journal-title":"Neurocrit Care"},{"issue":"3","key":"959_CR44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.52.3.583","volume":"52","author":"EM Manno","year":"1999","unstructured":"Manno EM, Adams RE, Derdeyn CP, Powers WJ, Diringer MN. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology. 1999;52(3):583\u20137.","journal-title":"Neurology"},{"issue":"4","key":"959_CR45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00002512-200421040-00005","volume":"21","author":"G Zuliani","year":"2004","unstructured":"Zuliani G, Cherubini A, Atti AR, et al. Prescription of anti-oedema agents and short-term mortality in older patients with acute ischaemic stroke. Drugs Aging. 2004;21(4):273\u20138.","journal-title":"Drugs Aging"},{"issue":"5","key":"959_CR46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40256-018-0285-0","volume":"18","author":"M Papagianni","year":"2018","unstructured":"Papagianni M, Tziomalos K, Kostaki S, et al. Treatment with Mannitol is associated with increased risk for in-hospital mortality in patients with acute ischemic stroke and cerebral Edema. Am J Cardiovasc Drugs. 2018;18(5):397\u2013403.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"959_CR47","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.STR.0000078658.52316.E8","volume":"34","author":"D Bereczki","year":"2003","unstructured":"Bereczki D, Mihalka L, Szatmari S, et al. Mannitol use in acute stroke: case fatality at 30\u00a0days and 1 year. Stroke. 2003;34(7):1730\u20135.","journal-title":"Stroke"},{"key":"959_CR48","first-page":"CD001153","volume":"3","author":"D Bereczki","year":"2007","unstructured":"Bereczki D, Fekete I, Prado GF, Liu M. Mannitol for acute stroke. Cochrane Database Syst Rev. 2007;3:CD001153.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"959_CR49","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/STROKEAHA.110.609479","volume":"42","author":"I Wagner","year":"2011","unstructured":"Wagner I, Hauer EM, Staykov D, et al. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke. 2011;42(6):1540\u20135.","journal-title":"Stroke"},{"issue":"1\u20132","key":"959_CR50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2005.03.038","volume":"234","author":"UK Misra","year":"2005","unstructured":"Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci. 2005;234(1\u20132):41\u20135.","journal-title":"J Neurol Sci"},{"issue":"10","key":"959_CR51","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/STROKEAHA.115.009357","volume":"46","author":"X Wang","year":"2015","unstructured":"Wang X, Arima H, Yang J, et al. Mannitol and outcome in intracerebral hemorrhage: propensity score and multivariable intensive blood pressure reduction in acute cerebral hemorrhage trial 2 results. Stroke. 2015;46(10):2762\u20137.","journal-title":"Stroke"},{"issue":"4","key":"959_CR52","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.013","volume":"27","author":"M Shah","year":"2018","unstructured":"Shah M, Birnbaum L, Rasmussen J, et al. Effect of hyperosmolar therapy on outcome following spontaneous intracerebral hemorrhage: ethnic\/racial variations of intracerebral hemorrhage (ERICH) study. J Stroke Cerebrovasc Dis. 2018;27(4):1061\u20137.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"959_CR53","doi-asserted-by":"crossref","unstructured":"Sun S, Li Y, Zhang H, et al. The effect of mannitol in the early stage of supratentorial hypertensive intracerebral hemorrhage: a systematic review and meta-analysis. World Neurosurg. 2019;124:386\u201396.","DOI":"10.1016\/j.wneu.2018.11.249"},{"key":"959_CR54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/2277-9175.192628","volume":"6","author":"B Aminmansour","year":"2017","unstructured":"Aminmansour B, Tabesh H, Rezvani M, Poorjafari H. Effects of mannitol 20% on outcomes in nontraumatic intracerebral hemorrhage. Adv Biomed Res. 2017;6:75.","journal-title":"Adv Biomed Res"},{"issue":"4","key":"959_CR55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.STR.4.4.541","volume":"4","author":"H Tellez","year":"1973","unstructured":"Tellez H, Bauer RB. Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke. 1973;4(4):541\u20136.","journal-title":"Stroke"},{"issue":"4","key":"959_CR56","first-page":"502","volume":"24","author":"N Sharafadinzadeh","year":"2008","unstructured":"Sharafadinzadeh N, Baghebanian SM, Pipelzadeh M, Moravej Ale Ali A, Ghanavati P. Effects of dexamethasone in primary intracerebral hemorrhage in the South West of Iran. Pak J Med Sci. 2008;24(4):502\u20135.","journal-title":"Pak J Med Sci"},{"issue":"12","key":"959_CR57","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1161\/STROKEAHA.111.632174","volume":"42","author":"I Zaganas","year":"2011","unstructured":"Zaganas I, Halpin AP, Oleinik A, et al. A comparison of acute hemorrhagic stroke outcomes in 2 populations: the Crete-Boston study. Stroke. 2011;42(12):3640\u20132.","journal-title":"Stroke"},{"issue":"3","key":"959_CR58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005053-196509000-00005","volume":"141","author":"MK Rubinstein","year":"1965","unstructured":"Rubinstein MK. The influence of adrenocortical steroids on severe cerebrovascular accidents. J Nerv Ment Dis. 1965;141(3):291\u20139.","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"959_CR59","first-page":"1","volume":"20","author":"SA Ogun","year":"2001","unstructured":"Ogun SA, Odusote KA. Effectiveness of high dose dexamethasone in the treatment of acute stroke. West Afr J Med. 2001;20(1):1\u20136.","journal-title":"West Afr J Med"},{"issue":"5","key":"959_CR60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jnnp.65.5.799a","volume":"65","author":"P Desai","year":"1998","unstructured":"Desai P, Prasad K. Dexamethasone is not necessarily unsafe in primary supratentorial intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1998;65(5):799\u2013800.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"959_CR61","first-page":"CD004583","volume":"3","author":"VL Feigin","year":"2005","unstructured":"Feigin VL, Anderson N, Rinkel GJE, Algra A, van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev. 2005;3:CD004583.","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"959_CR62","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJM198705143162001","volume":"316","author":"N Poungvarin","year":"1987","unstructured":"Poungvarin N, Bhoopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med. 1987;316(20):1229\u201333.","journal-title":"N Engl J Med"},{"key":"959_CR63","first-page":"CD004405","volume":"9","author":"MC Brouwer","year":"2015","unstructured":"Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;9:CD004405.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"959_CR64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1468-1331.2009.02615.x","volume":"16","author":"KZ Vardakas","year":"2009","unstructured":"Vardakas KZ, Matthaiou DK, Falagas ME. Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta-analysis of randomized controlled trials. Eur J Neurol. 2009;16(6):662\u201373.","journal-title":"Eur J Neurol"},{"key":"959_CR65","first-page":"CD004405","volume":"1","author":"D van de Beek","year":"2007","unstructured":"van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2007;1:CD004405.","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"959_CR66","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa065711","volume":"357","author":"M Scarborough","year":"2007","unstructured":"Scarborough M, Gordon SB, Whitty CJM, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med. 2007;357(24):2441\u201350.","journal-title":"N Engl J Med"},{"issue":"3","key":"959_CR67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(10)70023-5","volume":"9","author":"D van de Beek","year":"2010","unstructured":"van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 2010;9(3):254\u201363.","journal-title":"Lancet Neurol"},{"issue":"20","key":"959_CR68","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","volume":"347","author":"J de Gans","year":"2002","unstructured":"de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study I. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549\u201356.","journal-title":"N Engl J Med"},{"issue":"22","key":"959_CR69","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1212\/WNL.0b013e31827595f7","volume":"79","author":"D Fritz","year":"2012","unstructured":"Fritz D, Brouwer MC, van de Beek D. Dexamethasone and long-term survival in bacterial meningitis. Neurology. 2012;79(22):2177\u20139.","journal-title":"Neurology"},{"issue":"12","key":"959_CR70","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00006454-198912000-00004","volume":"8","author":"NI Girgis","year":"1989","unstructured":"Girgis NI, Farid Z, Mikhail IA, Farrag I, Sultan Y, Kilpatrick ME. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989;8(12):848\u201351.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"959_CR71","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267\u201384.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"959_CR72","doi-asserted-by":"crossref","first-page":"e91976","DOI":"10.1371\/journal.pone.0091976","volume":"9","author":"M Glimaker","year":"2014","unstructured":"Glimaker M, Johansson B, Halldorsdottir H, et al. Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study. PLoS ONE. 2014;9(3):e91976.","journal-title":"PLoS ONE"},{"issue":"4","key":"959_CR73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(10)70317-0","volume":"11","author":"KM Ajdukiewicz","year":"2011","unstructured":"Ajdukiewicz KM, Cartwright KE, Scarborough M, et al. Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis. 2011;11(4):293\u2013300.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"959_CR74","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/INF.0b013e318175d177","volume":"27","author":"S Singhi","year":"2008","unstructured":"Singhi S, Jarvinen A, Peltola H. Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis. Pediatr Infect Dis J. 2008;27(10):892\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"959_CR75","first-page":"64","volume":"6","author":"S Hosoglu","year":"2002","unstructured":"Hosoglu S, Geyik MF, Balik I, et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis. 2002;6(1):64\u201370.","journal-title":"Int J Tuberc Lung Dis"},{"key":"959_CR76","first-page":"002244","volume":"4","author":"K Prasad","year":"2016","unstructured":"Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:002244.","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"959_CR77","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","volume":"351","author":"GE Thwaites","year":"2004","unstructured":"Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741\u201351.","journal-title":"N Engl J Med"},{"issue":"2","key":"959_CR78","first-page":"83","volume":"79","author":"V Chotmongkol","year":"1996","unstructured":"Chotmongkol V, Jitpimolmard S, Thavornpitak Y. Corticosteroid in tuberculous meningitis. J Med Assoc Thailand\u2009=\u2009Chotmaihet thangphaet. 1996;79(2):83\u201390.","journal-title":"J Med Assoc Thailand\u2009=\u2009Chotmaihet thangphaet"},{"issue":"3","key":"959_CR79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0962-8479(94)90009-4","volume":"75","author":"S Kumarvelu","year":"1994","unstructured":"Kumarvelu S, Prasad K, Khosla A, Behari M, Ahuja GK. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tuber Lung Dis. 1994;75(3):203\u20137.","journal-title":"Tuber Lung Dis"},{"issue":"7","key":"959_CR80","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1179\/000349809X12502035776315","volume":"103","author":"HS Malhotra","year":"2009","unstructured":"Malhotra HS, Garg RK, Singh MK, Agarwal A, Verma R. Corticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with tuberculous meningitis. Ann Trop Med Parasitol. 2009;103(7):625\u201334.","journal-title":"Ann Trop Med Parasitol"},{"issue":"7","key":"959_CR81","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/gut.23.7.625","volume":"23","author":"J Canalese","year":"1982","unstructured":"Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23(7):625\u20139.","journal-title":"Gut"},{"issue":"2","key":"959_CR82","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/hep.20056","volume":"39","author":"N Murphy","year":"2004","unstructured":"Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology (Baltimore, Md.). 2004;39(2):464\u201370.","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"10","key":"959_CR83","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/gut.21.10.866","volume":"21","author":"MA Hanid","year":"1980","unstructured":"Hanid MA, Davies M, Mellon PJ, et al. Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut. 1980;21(10):866\u20139.","journal-title":"Gut"},{"issue":"26","key":"959_CR84","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.3748\/wjg.14.4168","volume":"14","author":"VA Saraswat","year":"2008","unstructured":"Saraswat VA, Saksena S, Nath K, et al. Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in vivo proton MR spectroscopy. World J Gastroenterol. 2008;14(26):4168\u201378.","journal-title":"World J Gastroenterol"},{"issue":"12 SUPPL. 1","key":"959_CR85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.ccm.0000474305.10317.fd","volume":"43","author":"E Liotta","year":"2015","unstructured":"Liotta E, Romanova A, Lizza B, et al. Association of osmolality, brain volume, and clinical neurologic changes in hepatic encephalopathy. Crit Care Med. 2015;43(12 SUPPL. 1):121.","journal-title":"Crit Care Med"},{"issue":"3","key":"959_CR86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-199005000-00003","volume":"69","author":"HR Dorman","year":"1990","unstructured":"Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore). 1990;69(3):153\u20139.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"959_CR87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0303-8467(02)00106-3","volume":"105","author":"T Dziedzic","year":"2003","unstructured":"Dziedzic T, Szczudlik A, Klimkowicz A, Rog TM, Slowik A. Is mannitol safe for patients with intracerebral hemorrhages? Renal considerations. Clin Neurol Neurosurg. 2003;105(2):87\u20139.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"959_CR88","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3171\/jns.2005.103.3.0444","volume":"103","author":"FdAA Gondim","year":"2005","unstructured":"Gondim FdAA, Aiyagari V, Shackleford A, Diringer MN. Osmolality not predictive of mannitol-induced acute renal insufficiency. J Neurosurg. 2005;103(3):444\u20137.","journal-title":"J Neurosurg"},{"issue":"47","key":"959_CR89","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1097\/MD.0000000000002032","volume":"94","author":"S-Y Lin","year":"2015","unstructured":"Lin S-Y, Tang S-C, Tsai L-K, et al. Incidence and risk factors for acute kidney injury following mannitol infusion in patients with acute stroke: a retrospective cohort study. Medicine. 2015;94(47):e2032.","journal-title":"Medicine"},{"issue":"4","key":"959_CR90","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00000441-199504000-00006","volume":"309","author":"MF Gadallah","year":"1995","unstructured":"Gadallah MF, Lynn M, Work J. Case report: mannitol nephrotoxicity syndrome: role of hemodialysis and postulate of mechanisms. Am J Med Sci. 1995;309(4):219\u201322.","journal-title":"Am J Med Sci"},{"issue":"4","key":"959_CR91","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.CCM.0000120057.04528.60","volume":"32","author":"EJ Garcia-Morales","year":"2004","unstructured":"Garcia-Morales EJ, Cariappa R, Parvin CA, Scott MG, Diringer MN. Osmole gap in neurologic-neurosurgical intensive care unit: its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med. 2004;32(4):986\u201391.","journal-title":"Crit Care Med"},{"issue":"2","key":"959_CR92","first-page":"223","volume":"141","author":"SP Temes","year":"1975","unstructured":"Temes SP, Lilien OM, Chamberlain W. A direct vasoconstrictor effect of mannitol on the renal artery. Surg Gynecol Obstet. 1975;141(2):223\u20136.","journal-title":"Surg Gynecol Obstet"},{"key":"959_CR93","volume-title":"Intracranial pressure","author":"DP Becker","year":"1972","unstructured":"Becker DP, Vries JK. The alleviation of increased intracranial pressure by the chronic administration of osmotic agents. In: Brock M, Dietz H, editors. Intracranial pressure. Berlin: Springer; 1972."},{"issue":"15","key":"959_CR94","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2012.13356","volume":"308","author":"NM Yunos","year":"2012","unstructured":"Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566\u201372.","journal-title":"JAMA"},{"issue":"1","key":"959_CR95","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12028-015-0234-6","volume":"25","author":"T Boland","year":"2016","unstructured":"Boland T, Henderson GV, Gibbons FK, et al. Hypernatremia at hospital discharge and out of hospital mortality following primary intracerebral hemorrhage. Neurocrit Care. 2016;25(1):110\u20136.","journal-title":"Neurocrit Care"},{"issue":"3","key":"959_CR96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1385\/NCC:5:3:180","volume":"5","author":"LA Fisher","year":"2006","unstructured":"Fisher LA, Ko N, Miss J, et al. Hypernatremia predicts adverse cardiovascular and neurological outcomes after SAH. Neurocrit Care. 2006;5(3):180\u20135.","journal-title":"Neurocrit Care"},{"issue":"7","key":"959_CR97","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12630-010-9309-1","volume":"57","author":"HT Stelfox","year":"2010","unstructured":"Stelfox HT, Ahmed SB, Zygun D, Khandwala F, Laupland K. Characterization of intensive care unit acquired hyponatremia and hypernatremia following cardiac surgery. Can J Anaesth. 2010;57(7):650\u20138.","journal-title":"Can J Anaesth"},{"key":"959_CR98","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jocn.2017.01.025","volume":"39","author":"KL Maguigan","year":"2017","unstructured":"Maguigan KL, Dennis BM, Hamblin SE, Guillamondegui OD. Method of hypertonic saline administration: effects on osmolality in traumatic brain injury patients. J Clin Neurosci. 2017;39:147\u201350.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"959_CR99","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/CCM.0b013e31819c1933","volume":"37","author":"M Froelich","year":"2009","unstructured":"Froelich M, Ni Q, Wess C, Ougorets I, Hartl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(4):1433\u201341.","journal-title":"Crit Care Med"},{"issue":"1","key":"959_CR100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1941874416665744","volume":"7","author":"MJ Erdman","year":"2017","unstructured":"Erdman MJ, Riha H, Bode L, Chang JJ, Jones GM. Predictors of acute kidney injury in neurocritical care patients receiving continuous hypertonic saline. Neurohospitalist. 2017;7(1):9\u201314.","journal-title":"Neurohospitalist"},{"issue":"4","key":"959_CR101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1385\/NCC:1:4:435","volume":"1","author":"LL Larive","year":"2004","unstructured":"Larive LL, Rhoney DH, Parker D Jr, Coplin WM, Carhuapoma JR. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit Care. 2004;1(4):435\u201340.","journal-title":"Neurocrit Care"},{"issue":"8","key":"959_CR102","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/jnnp.2008.156596","volume":"80","author":"M Oddo","year":"2009","unstructured":"Oddo M, Levine JM, Frangos S, et al. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry. 2009;80(8):916\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"959_CR103","first-page":"277","volume":"67","author":"AJ Kerwin","year":"2009","unstructured":"Kerwin AJ, Schinco MA, Tepas JJ 3rd, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009;67(2):277\u201382.","journal-title":"J Trauma"},{"issue":"8","key":"959_CR104","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/CCM.0000000000002497","volume":"45","author":"O Sadan","year":"2017","unstructured":"Sadan O, Singbartl K, Kandiah PA, Martin KS, Samuels OB. Hyperchloremia is associated with acute kidney injury in patients with subarachnoid hemorrhage. Crit Care Med. 2017;45(8):1382\u20138.","journal-title":"Crit Care Med"},{"issue":"2","key":"959_CR105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5492\/wjccm.v3.i2.61","volume":"3","author":"JJ Corry","year":"2014","unstructured":"Corry JJ, Varelas P, Abdelhak T, et al. Variable change in renal function by hypertonic saline. World J Crit Care Med. 2014;3(2):61\u20137.","journal-title":"World J Crit Care Med"},{"issue":"9","key":"959_CR106","doi-asserted-by":"crossref","first-page":"e947","DOI":"10.1097\/CCM.0000000000002522","volume":"45","author":"HM Riha","year":"2017","unstructured":"Riha HM, Erdman MJ, Vandigo JE, et al. Impact of moderate hyperchloremia on clinical outcomes in intracerebral hemorrhage patients treated with continuous infusion hypertonic saline: a pilot study. Crit Care Med. 2017;45(9):e947\u201353.","journal-title":"Crit Care Med"},{"issue":"3","key":"959_CR107","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00008506-199907000-00004","volume":"11","author":"JI Suarez","year":"1999","unstructured":"Suarez JI, Qureshi AI, Parekh PD, et al. Administration of hypertonic (3%) sodium chloride\/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1999;11(3):178\u201384.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"10","key":"959_CR108","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/CCM.0000000000002595","volume":"45","author":"SG Achinger","year":"2017","unstructured":"Achinger SG, Ayus JC. Treatment of hyponatremic encephalopathy in the critically Ill. Crit Care Med. 2017;45(10):1762\u201371.","journal-title":"Crit Care Med"},{"issue":"6","key":"959_CR109","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3171\/jns.1983.59.6.0938","volume":"59","author":"QJ Durward","year":"1983","unstructured":"Durward QJ, Amacher AL, Del Maestro RF, Sibbald WJ. Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension. J Neurosurg. 1983;59(6):938\u201344.","journal-title":"J Neurosurg"},{"issue":"2","key":"959_CR110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0090-3019(81)90037-9","volume":"15","author":"JA Kenning","year":"1981","unstructured":"Kenning JA, Toutant SM, Saunders RL. Upright patient positioning in the management of intracranial hypertension. Surg Neurol. 1981;15(2):148\u201352.","journal-title":"Surg Neurol"},{"issue":"5","key":"959_CR111","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3171\/jns.1986.65.5.0636","volume":"65","author":"MJ Rosner","year":"1986","unstructured":"Rosner MJ, Coley IB. Cerebral perfusion pressure, intracranial pressure, and head elevation. J Neurosurg. 1986;65(5):636\u201341.","journal-title":"J Neurosurg"},{"issue":"2","key":"959_CR112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3171\/jns.1992.76.2.0207","volume":"76","author":"Z Feldman","year":"1992","unstructured":"Feldman Z, Kanter MJ, Robertson CS, et al. Effect of head elevation on intracranial pressure, cerebral perfusion pressure, and cerebral blood flow in head-injured patients. J Neurosurg. 1992;76(2):207\u201311.","journal-title":"J Neurosurg"},{"issue":"4","key":"959_CR113","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3171\/jns.2000.92.4.0606","volume":"92","author":"JJ Moraine","year":"2000","unstructured":"Moraine JJ, Berre J, Melot C. Is cerebral perfusion pressure a major determinant of cerebral blood flow during head elevation in comatose patients with severe intracranial lesions? J Neurosurg. 2000;92(4):606\u201314.","journal-title":"J Neurosurg"},{"issue":"6","key":"959_CR114","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4037\/ajcc2000.9.6.373","volume":"9","author":"C Winkelman","year":"2000","unstructured":"Winkelman C. Effect of backrest position on intracranial and cerebral perfusion pressures in traumatically brain-injured adults. Am J Crit Care. 2000;9(6):373\u201380 (quiz 381\u2013372).","journal-title":"Am J Crit Care"},{"issue":"5","key":"959_CR115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JNN.0b013e3181ecafd4","volume":"42","author":"MB Ledwith","year":"2010","unstructured":"Ledwith MB, Bloom S, Maloney-Wilensky E, Coyle B, Polomano RC, Le Roux PD. Effect of body position on cerebral oxygenation and physiologic parameters in patients with acute neurological conditions. J Neurosci Nurs. 2010;42(5):280\u20137.","journal-title":"J Neurosci Nurs"},{"issue":"3","key":"959_CR116","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00701-009-0520-1","volume":"152","author":"F Mahfoud","year":"2010","unstructured":"Mahfoud F, Beck J, Raabe A. Intracranial pressure pulse amplitude during changes in head elevation: a new parameter for determining optimum cerebral perfusion pressure? Acta Neurochir (Wien). 2010;152(3):443\u201350.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"959_CR117","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1227\/01.NEU.0000108639.16783.39","volume":"54","author":"I Ng","year":"2004","unstructured":"Ng I, Lim J, Wong HB. Effects of head posture on cerebral hemodynamics: its influences on intracranial pressure, cerebral perfusion pressure, and cerebral oxygenation. Neurosurgery. 2004;54(3):593\u20137 (discussion 598).","journal-title":"Neurosurgery"},{"issue":"5","key":"959_CR118","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3171\/jns.2002.97.5.1045","volume":"97","author":"M Oertel","year":"2002","unstructured":"Oertel M, Kelly DF, Lee JH, et al. Efficacy of hyperventilation, blood pressure elevation, and metabolic suppression therapy in controlling intracranial pressure after head injury. J Neurosurg. 2002;97(5):1045\u201353.","journal-title":"J Neurosurg"},{"issue":"6","key":"959_CR119","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00005373-199512000-00014","volume":"39","author":"JB Fortune","year":"1995","unstructured":"Fortune JB, Feustel PJ, Graca L, Hasselbarth J, Kuehler DH. Effect of hyperventilation, mannitol, and ventriculostomy drainage on cerebral blood flow after head injury. J Trauma. 1995;39(6):1091\u20137 (discussion 1097\u20131099).","journal-title":"J Trauma"},{"issue":"8","key":"959_CR120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00701-006-0792-7","volume":"148","author":"JF Soustiel","year":"2006","unstructured":"Soustiel JF, Mahamid E, Chistyakov A, Shik V, Benenson R, Zaaroor M. Comparison of moderate hyperventilation and mannitol for control of intracranial pressure control in patients with severe traumatic brain injury\u2013a study of cerebral blood flow and metabolism. Acta Neurochir. 2006;148(8):845\u201351.","journal-title":"Acta Neurochir"},{"issue":"5","key":"959_CR121","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3171\/jns.1991.75.5.0731","volume":"75","author":"JP Muizelaar","year":"1991","unstructured":"Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75(5):731\u20139.","journal-title":"J Neurosurg"},{"issue":"4","key":"959_CR122","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00008506-200010000-00005","volume":"12","author":"EM Kerr","year":"2000","unstructured":"Kerr EM, Marion D, Sereika MS, et al. The effect of cerebrospinal fluid drainage on cerebral perfusion in traumatic brain injured adults. J Neurosurg Anesthesiol. 2000;12(4):324\u201333.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"4","key":"959_CR123","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2001.11.4.2","volume":"11","author":"ME Kerr","year":"2001","unstructured":"Kerr ME, Weber BB, Sereika SM, Wilberger J, Marion DW. Dose response to cerebrospinal fluid drainage on cerebral perfusion in traumatic brain-injured adults. Neurosurg Focus. 2001;11(4):E1.","journal-title":"Neurosurg Focus"},{"issue":"2","key":"959_CR124","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12028-018-0612-y","volume":"30","author":"C Candanedo","year":"2019","unstructured":"Candanedo C, Doron O, Hemphill JC, 3rd, et al. Characterizing the response to cerebrospinal fluid drainage in patients with an external ventricular drain: the pressure equalization ratio. Neurocrit Care 2019;30(2):340\u20137.","journal-title":"Neurocrit Care"},{"issue":"1","key":"959_CR125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12028-013-9885-3","volume":"20","author":"EL Nwachuku","year":"2014","unstructured":"Nwachuku EL, Puccio AM, Fetzick A, et al. Intermittent versus continuous cerebrospinal fluid drainage management in adult severe traumatic brain injury: assessment of intracranial pressure burden. Neurocrit Care. 2014;20(1):49\u201353.","journal-title":"Neurocrit Care"},{"issue":"5","key":"959_CR126","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1227\/00006123-197911000-00005","volume":"5","author":"AB Levin","year":"1979","unstructured":"Levin AB, Duff TA, Javid MJ. Treatment of increased intracranial pressure: a comparison of different hyperosmotic agents and the use of thiopental. Neurosurgery. 1979;5(5):570\u20135.","journal-title":"Neurosurgery"},{"issue":"4","key":"959_CR127","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1017\/S0317167100045960","volume":"11","author":"ML Schwartz","year":"1984","unstructured":"Schwartz ML, Tator CH, Rowed DW. The University of Toronto head injury treatment study: a prospective, randomized comparison of Pentobarbital and Mannitol. Can J Neurol Sci. 1984;11(4):434\u201340.","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"959_CR128","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3171\/jns.1986.65.6.0820","volume":"65","author":"HP Smith","year":"1986","unstructured":"Smith HP, Kelly DL Jr, McWhorter JM, et al. Comparison of mannitol regimens in patients with severe head injury undergoing intracranial monitoring. J Neurosurg. 1986;65(6):820\u20134.","journal-title":"J Neurosurg"},{"key":"959_CR129","doi-asserted-by":"crossref","unstructured":"Midgely S, Dearden NM, Miller JD. CPP and SJO2 with ICP reduction therapy after severe head injury. In: Avezaat CJJ, Eijndhoven JHM, van Maas AIR, Tans JTJ, editors. Proceedings of the 8th International Symposium on Intracranial Pressure, Held in Rotterdam, The Netherlands, June 16\u201320, 1991. New York: Springer; 1993. p. 558\u2013563.","DOI":"10.1007\/978-3-642-77789-9_121"},{"key":"959_CR130","doi-asserted-by":"crossref","unstructured":"Smedema RJ, Gaab MR, Heissler HE. A comparison study between mannitol and glycerol therapy in reducing intracranial pressure. In: Avezaat CJJ, Eijndhoven JHM, van Maas AIR, Tans JTJ, editors. Proceedings of the 8th International Symposium on Intracranial Pressure, Held in Rotterdam, The Netherlands, June 16\u201320, 1991. New York: Springer; 1993. p. 605\u2013608.","DOI":"10.1007\/978-3-642-77789-9_131"},{"issue":"8","key":"959_CR131","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF01420045","volume":"139","author":"A Biestro","year":"1997","unstructured":"Biestro A, Alberti R, Galli R, et al. Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol. Acta Neurochir (Wien). 1997;139(8):725\u201332 (discussion 732\u2013723).","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"959_CR132","first-page":"181","volume":"122","author":"R Hartl","year":"1997","unstructured":"Hartl R, Ghajar J, Hochleuthner H, Mauritz W. Treatment of refractory intracranial hypertension in severe traumatic brain injury with repetitive hypertonic\/hyperoncotic infusions. Zentralbl Chir. 1997;122(3):181\u20135.","journal-title":"Zentralbl Chir"},{"key":"959_CR133","first-page":"40","volume":"70","author":"R Hartl","year":"1997","unstructured":"Hartl R, Bardt TF, Kiening KL, Sarrafzadeh AS, Schneider GH, Unterberg AW. Mannitol decreases ICP but does not improve brain-tissue pO2 in severely head-injured patients with intracranial hypertension. Acta Neurochir Suppl. 1997;70:40\u20132.","journal-title":"Acta Neurochir Suppl"},{"issue":"1","key":"959_CR134","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00005373-199801000-00004","volume":"44","author":"SR Shackford","year":"1998","unstructured":"Shackford SR, Bourguignon PR, Wald SL, Rogers FB, Osler TM, Clark DE. Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma. 1998;44(1):50\u20138.","journal-title":"J Trauma"},{"key":"959_CR135","first-page":"31","volume":"71","author":"C Schatzmann","year":"1998","unstructured":"Schatzmann C, Heissler HE, Konig K, et al. Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients. Acta Neurochir Suppl. 1998;71:31\u20133.","journal-title":"Acta Neurochir Suppl"},{"issue":"4","key":"959_CR136","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00005373-199910000-00009","volume":"47","author":"AI Qureshi","year":"1999","unstructured":"Qureshi AI, Suarez JI, Castro A, Bhardwaj A. Use of hypertonic saline\/acetate infusion in treatment of cerebral edema in patients with head trauma: experience at a single center. J Trauma. 1999;47(4):659\u201365.","journal-title":"J Trauma"},{"issue":"8","key":"959_CR137","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/01616412.1999.11741010","volume":"21","author":"P Horn","year":"1999","unstructured":"Horn P, Munch E, Vajkoczy P, et al. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res. 1999;21(8):758\u201364.","journal-title":"Neurol Res"},{"issue":"1","key":"959_CR138","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/neu.2000.17.41","volume":"17","author":"F Munar","year":"2000","unstructured":"Munar F, Ferrer AM, de Nadal M, et al. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma. 2000;17(1):41\u201351.","journal-title":"J Neurotrauma"},{"issue":"6","key":"959_CR139","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.surneu.2005.11.019","volume":"65","author":"SJ Huang","year":"2006","unstructured":"Huang SJ, Chang L, Han YY, Lee YC, Tu YK. Efficacy and safety of hypertonic saline solutions in the treatment of severe head injury. Surg Neurol. 2006;65(6):539\u201346 (discussion 546).","journal-title":"Surg Neurol"},{"issue":"12","key":"959_CR140","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1097\/01.CCM.0000243797.42346.64","volume":"34","author":"T Lescot","year":"2006","unstructured":"Lescot T, Degos V, Zouaoui A, Preteux F, Coriat P, Puybasset L. Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med. 2006;34(12):3029\u201333.","journal-title":"Crit Care Med"},{"issue":"2","key":"959_CR141","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0973-0508(07)80023-2","volume":"4","author":"N Chatterjee","year":"2007","unstructured":"Chatterjee N, Chaudhury A, Mukherjee S, Prusty GK, Chattopadhyay T, Saha S. Efficacy of different hypertonic solutes in the treatment of refractory intracranial hypertension in severe head injury patients: A comparative study of 2\u00a0ml\/kg 7.5% hypertonic saline and 2\u00a0ml\/kg 20% mannitol. Indian J Neurotrauma. 2007;4(2):101\u20138.","journal-title":"Indian J Neurotrauma"},{"issue":"4","key":"959_CR142","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcrc.2010.08.021","volume":"26","author":"LJ Morrison","year":"2011","unstructured":"Morrison LJ, Baker AJ, Rhind SG, et al. The Toronto prehospital hypertonic resuscitation\u2013head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. J Crit Care. 2011;26(4):363\u201372.","journal-title":"J Crit Care"},{"issue":"5","key":"959_CR143","doi-asserted-by":"crossref","first-page":"R260","DOI":"10.1186\/cc10522","volume":"15","author":"A Roquilly","year":"2011","unstructured":"Roquilly A, Mahe PJ, Latte DD, et al. Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study. Crit Care. 2011;15(5):R260.","journal-title":"Crit Care"},{"issue":"1","key":"959_CR144","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3171\/2014.10.JNS132545","volume":"122","author":"HS Mangat","year":"2015","unstructured":"Mangat HS, Chiu Y-L, Gerber LM, Alimi M, Ghajar J, Hartl R. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury. J Neurosurg. 2015;122(1):202\u201310.","journal-title":"J Neurosurg"},{"issue":"4","key":"959_CR145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0885066614555692","volume":"31","author":"K Colton","year":"2016","unstructured":"Colton K, Yang S, Hu PF, et al. pharmacologic treatment reduces pressure times time dose and relative duration of intracranial hypertension. J Intensive care Med. 2016;31(4):263\u20139.","journal-title":"J Intensive care Med"},{"issue":"6","key":"959_CR146","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12630-016-0633-y","volume":"63","author":"SK Tan","year":"2016","unstructured":"Tan SK, Kolmodin L, Sekhon MS, et al. The effect of continuous hypertonic saline infusion and hypernatremia on mortality in patients with severe traumatic brain injury: a retrospective cohort study. Can J Anaesth. 2016;63(6):664\u201373.","journal-title":"Can J Anaesth"},{"key":"959_CR147","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3389\/fneur.2018.00631","volume":"9","author":"F Cheng","year":"2018","unstructured":"Cheng F, Xu M, Liu H, Wang W, Wang Z. A retrospective study of intracranial pressure in head-injured patients undergoing decompressive craniectomy: a comparison of hypertonic saline and mannitol. Front Neurol. 2018;9:631.","journal-title":"Front Neurol"},{"issue":"3","key":"959_CR148","first-page":"40","volume":"8","author":"CM Dunham","year":"2018","unstructured":"Dunham CM, Malik RJ, Huang GS, Kohli CM, Brocker BP, Ugokwe KT. Hypertonic saline administration and complex traumatic brain injury outcomes: a retrospective study. Int J Burns Trauma. 2018;8(3):40\u201353.","journal-title":"Int J Burns Trauma"},{"key":"959_CR149","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.wneu.2019.01.051","volume":"125","author":"H Patil","year":"2019","unstructured":"Patil H, Gupta R. A comparative study of bolus dose of hypertonic saline, mannitol, and mannitol plus glycerol combination in patients with severe traumatic brain injury. World Neurosurg. 2019;125:e221\u20138.","journal-title":"World Neurosurg"},{"issue":"2","key":"959_CR150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/neuros\/nyz046","volume":"86","author":"HS Mangat","year":"2020","unstructured":"Mangat HS, Wu X, Gerber LM, et al. Hypertonic saline is superior to mannitol for the combined effect on intracranial pressure and cerebral perfusion pressure burdens in patients with severe traumatic brain injury. Neurosurgery 2020;86(2):221\u201330.","journal-title":"Neurosurgery"},{"issue":"4","key":"959_CR151","first-page":"213","volume":"37","author":"M Onar","year":"1997","unstructured":"Onar M, Arik Z. The evaluation of mannitol therapy in acute ischemic stroke patients by serial somatosensory evoked potentials. Electromyogr Clin Neurophysiol. 1997;37(4):213\u20138.","journal-title":"Electromyogr Clin Neurophysiol"},{"issue":"11","key":"959_CR152","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/WNL.57.11.2120","volume":"57","author":"TO Videen","year":"2001","unstructured":"Videen TO, Zazulia AR, Manno EM, et al. Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology. 2001;57(11):2120\u20132.","journal-title":"Neurology"},{"issue":"7590","key":"959_CR153","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/bmj.39118.480023.BE","volume":"334","author":"I Roberts","year":"2007","unstructured":"Roberts I, Smith R, Evans S. Doubts over head injury studies. BMJ. 2007;334(7590):392\u20134.","journal-title":"BMJ"},{"issue":"6","key":"959_CR154","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.1963.63700060029012","volume":"183","author":"I Bennett","year":"1963","unstructured":"Bennett I, Finland M, Hamburger M, Kass EH, Lepper M, Waisbren BA. The effectiveness of hydrocortisone in the managment of severe infections. J Am Med Assoc. 1963;183(6):462\u20135.","journal-title":"J Am Med Assoc"},{"issue":"1","key":"959_CR155","first-page":"53","volume":"31","author":"O Bademosi","year":"1979","unstructured":"Bademosi O, Osuntokun BO. Prednisolone in the treatment of pneumococcal meningitis. Trop Geogr Med. 1979;31(1):53\u20136.","journal-title":"Trop Geogr Med"},{"issue":"2","key":"959_CR156","first-page":"90","volume":"44","author":"A Gupta","year":"1996","unstructured":"Gupta A, Singh NK. Dexamethasone in adults with bacterial meningitis. J Assoc Phys India. 1996;44(2):90\u20132.","journal-title":"J Assoc Phys India"},{"issue":"3","key":"959_CR157","first-page":"225","volume":"46","author":"S Bhaumik","year":"1998","unstructured":"Bhaumik S, Behari M. Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurol India. 1998;46(3):225\u20138.","journal-title":"Neurol India"},{"issue":"5","key":"959_CR158","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s001340050883","volume":"25","author":"R Thomas","year":"1999","unstructured":"Thomas R, Le Tulzo Y, Bouget J, et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Med. 1999;25(5):475\u201380.","journal-title":"Intensive Care Med"},{"issue":"6","key":"959_CR159","first-page":"233","volume":"52","author":"T Ahsan","year":"2002","unstructured":"Ahsan T, Shahid M, Mahmood T, et al. Role of dexamethasone in acute bacterial meningitis in adults. JPMA J Pak Med Assoc. 2002;52(6):233\u20139.","journal-title":"JPMA J Pak Med Assoc"},{"issue":"5","key":"959_CR160","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/ajrccm.165.5.2105110","volume":"165","author":"M Auburtin","year":"2002","unstructured":"Auburtin M, Porcher R, Bruneel F, et al. Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med. 2002;165(5):713\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"959_CR161","first-page":"63","volume":"50","author":"D Gijwani","year":"2002","unstructured":"Gijwani D, Kumhar MR, Singh VB, et al. Dexamethasone therapy for bacterial meningitis in adults: a double blind placebo control study. Neurol India. 2002;50(1):63\u20137.","journal-title":"Neurol India"},{"issue":"11","key":"959_CR162","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00134-003-1935-4","volume":"29","author":"JM Flores-Cordero","year":"2003","unstructured":"Flores-Cordero JM, Amaya-Villar R, Rincon-Ferrari MD, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors. Intensive Care Med. 2003;29(11):1967\u201373.","journal-title":"Intensive Care Med"},{"issue":"4","key":"959_CR163","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ana.20944","volume":"60","author":"M Weisfelt","year":"2006","unstructured":"Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol. 2006;60(4):456\u201368.","journal-title":"Ann Neurol"},{"issue":"2","key":"959_CR164","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10096-006-0089-z","volume":"25","author":"M Weisfelt","year":"2006","unstructured":"Weisfelt M, van de Beek D, de Gans J. Dexamethasone treatment in adults with pneumococcal meningitis: risk factors for death. Eur J Clin Microbiol Infect Dis. 2006;25(2):73\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"959_CR165","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/jnnp.2006.110023","volume":"78","author":"M Hoogman","year":"2007","unstructured":"Hoogman M, Van De Beek D, Weisfelt M, De Gans J, Schmand B. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry. 2007;78(10):1092\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"959_CR166","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa070852","volume":"357","author":"THM Nguyen","year":"2007","unstructured":"Nguyen THM, Tran THC, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med. 2007;357(24):2431\u201340.","journal-title":"N Engl J Med"},{"issue":"2","key":"959_CR167","first-page":"146","volume":"13","author":"C Ayaz","year":"2008","unstructured":"Ayaz C, Celen MK, Geyik MF, Ulug M. The efficacy of dexamethasone treatment in adult patients with acute bacterial meningitis. Neurosciences. 2008;13(2):146\u201350.","journal-title":"Neurosciences"},{"issue":"4","key":"959_CR168","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1179\/joc.2008.20.4.478","volume":"20","author":"L Lazzarini","year":"2008","unstructured":"Lazzarini L, Toti M, Fabris P, et al. Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study. J Chemother (Florence, Italy). 2008;20(4):478\u201387.","journal-title":"J Chemother (Florence, Italy)"},{"issue":"5","key":"959_CR169","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0025-6196(11)60558-2","volume":"84","author":"AM Assiri","year":"2009","unstructured":"Assiri AM, Alasmari FA, Zimmerman VA, Baddour LM, Erwin PJ, Tleyjeh IM. Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta-analysis. Mayo Clin Proc. 2009;84(5):403\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"959_CR170","first-page":"228","volume":"64","author":"I Tolaj","year":"2010","unstructured":"Tolaj I, Dreshaj S, Qehaja E, Tolaj J, Doda-Ejupi T, Mehmeti M. Dexamethasone as adjuvant therapy in the treatment of invasive meningococcal diseases. Med Arh. 2010;64(4):228\u201330.","journal-title":"Med Arh"},{"issue":"17","key":"959_CR171","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.0b013e3181f96297","volume":"75","author":"MC Brouwer","year":"2010","unstructured":"Brouwer MC, Heckenberg SGB, De Gans J, Spanjaard L, Reitsma JB, Van De Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology. 2010;75(17):1533\u20139.","journal-title":"Neurology"},{"issue":"15","key":"959_CR172","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/WNL.0b013e31826e2684","volume":"79","author":"SGB Heckenberg","year":"2012","unstructured":"Heckenberg SGB, Brouwer MC, Van Der Ende A, Van De Beek D. Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology. 2012;79(15):1563\u20139.","journal-title":"Neurology"},{"issue":"7","key":"959_CR173","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00415-011-6373-6","volume":"259","author":"S-Y Moon","year":"2012","unstructured":"Moon S-Y, Chung DR, Kim S-W, et al. Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone? J Neurol. 2012;259(7):1453\u201360.","journal-title":"J Neurol"},{"issue":"6","key":"959_CR174","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/00365548.2014.887223","volume":"46","author":"J Bodilsen","year":"2014","unstructured":"Bodilsen J, Dalager-Pedersen M, Schonheyder HC, Nielsen H. Dexamethasone treatment and prognostic factors in community-acquired bacterial meningitis: a Danish retrospective population-based cohort study. Scand J Infect Dis. 2014;46(6):418\u201325.","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"959_CR175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcrc.2013.12.001","volume":"29","author":"D Fernandes","year":"2014","unstructured":"Fernandes D, Goncalves-Pereira J, Janeiro S, Silvestre J, Bento L, Povoa P. Acute bacterial meningitis in the intensive care unit and risk factors for adverse clinical outcomes: retrospective study. J Crit Care. 2014;29(3):347\u201350.","journal-title":"J Crit Care"},{"issue":"9","key":"959_CR176","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/1060028015586012","volume":"49","author":"P Viale","year":"2015","unstructured":"Viale P, Scudeller L, Pea F, et al. Implementation of a meningitis care bundle in the emergency room reduces mortality associated with acute bacterial meningitis. Ann Pharmacother. 2015;49(9):978\u201385.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"959_CR177","first-page":"281","volume":"48","author":"G Baunbaek-Knudsen","year":"2016","unstructured":"Baunbaek-Knudsen G, Solling M, Farre A, Benfield T, Brandt CT. Improved outcome of bacterial meningitis associated with use of corticosteroid treatment. Infect Dis (London, England). 2016;48(4):281\u20136.","journal-title":"Infect Dis (London, England)"},{"issue":"1","key":"959_CR178","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13054-016-1498-8","volume":"20","author":"G Buchholz","year":"2016","unstructured":"Buchholz G, Koedel U, Pfister HW, Kastenbauer S, Klein M. Dramatic reduction of mortality in pneumococcal meningitis. Crit Care. 2016;20(1):312.","journal-title":"Crit Care"},{"issue":"7","key":"959_CR179","doi-asserted-by":"crossref","first-page":"e0200067","DOI":"10.1371\/journal.pone.0200067","volume":"13","author":"EK Gudina","year":"2018","unstructured":"Gudina EK, Tesfaye M, Wieser A, Pfister HW, Klein M. Outcome of patients with acute bacterial meningitis in a teaching hospital in Ethiopia: a prospective study. PLoS ONE. 2018;13(7):e0200067.","journal-title":"PLoS ONE"},{"issue":"1","key":"959_CR180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/0003-4819-70-1-39","volume":"70","author":"RD O\u2019Toole","year":"1969","unstructured":"O\u2019Toole RD, Thornton GF, Mukherjee MK, Nath RL. Dexamethasone in tuberculous meningitis. Relationship of cerebrospinal fluid effects to therapeutic efficacy. Ann Intern Med. 1969;70(1):39\u201348.","journal-title":"Ann Intern Med"},{"issue":"3","key":"959_CR181","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00006454-199103000-00002","volume":"10","author":"NI Girgis","year":"1991","unstructured":"Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J. 1991;10(3):179\u201383.","journal-title":"Pediatr Infect Dis J"},{"issue":"15","key":"959_CR182","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinte.1996.00440140144014","volume":"156","author":"VK Yechoor","year":"1996","unstructured":"Yechoor VK, Shandera WX, Rodriguez P, Cate TR. Tuberculous meningitis among adults with and without HIV infection: experience in an urban public hospital. Arch Intern Med. 1996;156(15):1710\u20136.","journal-title":"Arch Intern Med"},{"issue":"3","key":"959_CR183","first-page":"267","volume":"49","author":"J Kalita","year":"2001","unstructured":"Kalita J, Misra UK. Effect of methyl prednisolone on sensory motor functions in tuberculous meningitis. Neurol India. 2001;49(3):267\u201371.","journal-title":"Neurol India"},{"issue":"1","key":"959_CR184","first-page":"47","volume":"18","author":"ML Rahman","year":"2009","unstructured":"Rahman ML, Basher A, Rashid M, et al. Central nervous system tuberculosis and adjuvant corticosteroid therapy. Mymensingh Med J MMJ. 2009;18(1):47\u201351.","journal-title":"Mymensingh Med J MMJ"},{"issue":"2","key":"959_CR185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1684-1182(10)60018-7","volume":"43","author":"PC Hsu","year":"2010","unstructured":"Hsu PC, Yang CC, Ye JJ, Huang PY, Chiang PC, Lee MH. Prognostic factors of tuberculous meningitis in adults: a 6-year retrospective study at a tertiary hospital in Northern Taiwan. J Microbiol Immunol Infect. 2010;43(2):111\u20138.","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"959_CR186","doi-asserted-by":"crossref","first-page":"e27821","DOI":"10.1371\/journal.pone.0027821","volume":"6","author":"ME Torok","year":"2011","unstructured":"Torok ME, Nguyen DB, Tran THC, et al. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS ONE. 2011;6(12):e27821.","journal-title":"PLoS ONE"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00959-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-020-00959-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00959-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T19:52:55Z","timestamp":1621021975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-020-00959-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":186,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1007\/s12028-020-00959-7","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"assertion":[{"value":"15 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}